Fifty-two week follow-up safety and effectiveness results of dupilumab treatment of moderate-to-severe atopic dermatitis from a retrospective, multicentric series

Artículo original

Año: 2019

Ruiz-Villaverde, R; Dominguez-Cruz, J; Armario-Hita, JC; Martinez-Pilar, L; Alcantara-Luna, S; Pereyra-Rodriguez, JJ

Título: DERMATOLOGIC THERAPY

• Q3